WHO ICTRP trial
Clinical observation of Liushen pill in the treatment of COVID-19 Infection…
ChiCTR2200058859 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200058859 |
|---|---|
| Public title | Clinical observation of Liushen pill in the treatment of COVID-19 Infection (asymptomatic infection, mild/normal type) |
| Scientific title | Clinical observation of Liushen pill in the treatment of COVID-19 Infection (asymptomatic infection, mild/normal type) |
| Primary sponsor | The Fifth People's Hospital of Suzhou |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | COVID-19 infection |
| Interventions | Control group:Malt date tea;Experimental group:Malt date tea and liushen pill |
| Registration date | Apr 18, 2022 |
| Target size | Control group:100;Experimental group:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: